Study of Immune System Role in Colorectal Cancer Development in Adults with Lynch Syndrome
Led by San Raffaele University · Updated on 2026-04-24
300
Participants Needed
5
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Lynch syndrome is a common inherited condition that increases the risk of colorectal and endometrial cancers, among others, due to genetic mutations affecting DNA repair. Despite regular cancer screenings, many patients still develop colorectal cancer, and the reasons behind this are unclear. This research investigates the interaction between the intestinal lining and the immune system to better understand early cancer development and identify biological markers and processes that may help in prevention.
The study analyzes blood, mucosal tissue, and hair samples to measure microRNAs, antibodies against specific peptides, bacteria present in colon tissue, and environmental exposures to carcinogens. Participants include groups with Lynch syndrome gene mutations both with and without colorectal cancer or advanced adenomas, as well as individuals without these mutations but with various colorectal conditions. This observational study looks at immune and microbiome profiles to find early signs of cancer and better understand disease mechanisms.
Participants will undergo regular clinical evaluations, including gastrointestinal endoscopy and sample collection of blood, mucosa, and hair. Researchers will assess immune responses, tumor microbiomes, and environmental factors, measuring outcomes such as sensitivity and specificity of biomarkers over about one year. The study aims to improve early cancer detection and prevention strategies by closely monitoring biological indicators and immune surveillance in high-risk individuals.
CONDITIONS
Brief Title
Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
Research Team
G
Giulia Martina Cavestro, MD, PhD
A
Alessandro Mannucci, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Confirmed diagnosis of Lynch syndrome with a germline pathogenic variant in MLH1, MSH2, MSH6, PMS2, or EpCAM genes
Undergoing surveillance gastrointestinal endoscopy and/or surgery according to clinical practice
Fertile patients, both males and females, are eligible
Lactating women are eligible
Patients without Lynch syndrome aged 18 years or older
Patients with sporadic colorectal lesions including colorectal cancer and adenomas
Healthy controls without colorectal cancer or adenomas undergoing lower gastrointestinal endoscopy for abdominal pain
PREMM5 score less than 2.5
You will not qualify if you...
Age under 18 years
Personal past or recent history of inflammatory bowel disease
Unable or unwilling to provide consent
Pregnancy
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Diagnostic Evaluation
Duration - Up to 1 year
Participants undergo a combination of blood-based, mucosal-based, and hair-based analyses to evaluate early biomarkers and biological signatures related to colorectal cancer risk in Lynch syndrome, including microRNA expression, anti-frame-shift peptide antibodies, mucosal-resident bacteria, and environmental exposure to potential carcinogens.
Periodic visits as per clinical practice during surveillance gastrointestinal endoscopy and/or surgery
Long-term Monitoring
Duration - Up to 1 year
Participants are observed over time to monitor biomarkers, tumor microbiome, immuno-environmental signatures, and exposure analysis to understand early cancer development and risk in Lynch syndrome.
Follow-up visits aligned with routine surveillance endoscopy and clinical care
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
14
Similar Trials
Phase IIa Study of Naproxen or Aspirin for Immune Effects and Cancer Prevention in Adults with Lynch Syndrome
Pilot Study Using a Retrograde Tethered Capsule Endomicroscope to Image the Lower Gastrointestinal Tract in Adults
Improving Genetic Education and Testing for Hereditary Cancer Risk
Among Black Cancer Survivors Using a Chatbot Compared to Usual Care
Digital Tools to Improve Genetic Testing and Follow-Up for Cancer Risk Genes EfFORT and STRIVE Trials Comparing Provider Outreach and Online Portal Use
Evaluating Self-Collected Vaginal Samples to Detect Uterine Cancer Risk in Women with Lynch Syndrome
Testing the CAD EYE System Versus Indigo Carmine Chromoendoscopy for Detecting Colorectal Lesions in Adults with Lynch Syndrome
Study of Cascade Genetic Testing for Hereditary BreastOvarian Cancer and Lynch Syndrome in Switzerland
Tracking Mutation Carriers and Their Family Members to Improve Cancer Prevention
Evaluating Cell-free DNA Blood Testing for Early Cancer Detection in Hereditary and High-risk Cancer Syndromes
Study of a Chatbot to Improve Genetic Risk Assessment for Hereditary Cancer in Gynecology Patients
Evaluating Stool DNA Testing for Detecting Colorectal Cancer in Lynch Syndrome Patients The CORAL Study
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Correspondence on "Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database" by Dominguez-Valentin et al.
Ramadhani Chambuso, Evelyn Kaambo, George Rebello...